ABREVA

LOE Approaching

docosanol

NDATOPICALCREAM

Approved

Jul 2000

Lifecycle

LOE Approaching

Competitive Pressure

30/100

Indications (6)

cold sores/fever blisters on the face lips shortens healing time duration of symptoms: tingling pain burning and/or itching

Company

LONDON, United Kingdom

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers